Sally Worsley
Publications by Year
Research Areas
Chronic Obstructive Pulmonary Disease (COPD) Research, Asthma and respiratory diseases, Pharmacological Effects and Assays, Respiratory and Cough-Related Research, Inhalation and Respiratory Drug Delivery
Most-Cited Works
- → Overexpression of Cyclin D1 in Epithelial Ovarian Cancers(1997)99 cited
- → Series: Pragmatic trials and real world evidence: Paper 3. Patient selection challenges and consequences(2017)90 cited
- → Improvements in lung function with umeclidinium/vilanterol versus fluticasone propionate/salmeterol in patients with moderate-to-severe COPD and infrequent exacerbations(2015)81 cited
- → INTREPID: single-versusmultiple-inhaler triple therapy for COPD in usual clinical practice(2021)67 cited
- → Umeclidinium/vilanterol versus fluticasone propionate/salmeterol in COPD: a randomised trial(2015)62 cited
- → Targeting phosphoinositide 3‐kinase δ for the treatment of respiratory diseases(2013)61 cited
- → Series: Pragmatic trials and real world evidence: Paper 2. Setting, sites, and investigator selection(2017)42 cited
- → IL1RAP expression and the enrichment of IL‐33 activation signatures in severe neutrophilic asthma(2022)40 cited
- → Mapping atopic dermatitis and anti–IL-22 response signatures to type 2–low severe neutrophilic asthma(2021)33 cited
- → Randomized controlled trials and real-world observational studies in evaluating cardiovascular safety of inhaled bronchodilator therapy in COPD(2016)25 cited